LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 84

Search options

  1. Article: The contribution of neutrophils to bacteriophage clearance and pharmacokinetics in vivo.

    Echterhof, Arne / Dharmaraj, Tejas / McBride, Robert / Berry, Joel / Hopkins, Max / Selvakumar, Hemaa / Miesel, Lynn / Chia, Ju-Hsin / Lin, Kun-Yuan / Shen, Chien-Chang / Lee, Yu-Ling / Yeh, Yu-Chuan / Liao, Wei Ting / Suh, Gina / Blankenberg, Francis G / Frymoyer, Adam R / Bollyky, Paul L

    bioRxiv : the preprint server for biology

    2024  

    Abstract: With the increasing prevalence of antimicrobial-resistant bacterial infections, there is great interest in using lytic bacteriophages (phages) to treat such infections. However, the factors that govern bacteriophage ... ...

    Abstract With the increasing prevalence of antimicrobial-resistant bacterial infections, there is great interest in using lytic bacteriophages (phages) to treat such infections. However, the factors that govern bacteriophage pharmacokinetics
    Language English
    Publishing date 2024-01-27
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2024.01.25.577154
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: A novel roadmap connecting the

    Iorio, Egidio / Podo, Franca / Leach, Martin O / Koutcher, Jason / Blankenberg, Francis G / Norfray, Joseph F

    European radiology experimental

    2021  Volume 5, Issue 1, Page(s) 5

    Abstract: This review describes a cellular adaptive stress signalling roadmap connecting ... ...

    Abstract This review describes a cellular adaptive stress signalling roadmap connecting the
    MeSH term(s) Choline ; Humans ; Magnetic Resonance Spectroscopy ; Neoplasms/diagnostic imaging ; Neoplasms/drug therapy ; Proton Magnetic Resonance Spectroscopy ; Retrospective Studies
    Chemical Substances Choline (N91BDP6H0X)
    Language English
    Publishing date 2021-01-15
    Publishing country England
    Document type Journal Article ; Review
    ISSN 2509-9280
    ISSN (online) 2509-9280
    DOI 10.1186/s41747-020-00192-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Apoptosis imaging: anti-cancer agents in medicinal chemistry.

    Blankenberg, Francis G

    Anti-cancer agents in medicinal chemistry

    2010  Volume 9, Issue 9, Page(s) 944–951

    Abstract: There is a rapid expansion in the number of new anti-cancer drugs with remarkably different mechanisms of action that can augment traditional chemotherapy. As these agents are often used in combination with traditional chemotherapy testing the effects of ...

    Abstract There is a rapid expansion in the number of new anti-cancer drugs with remarkably different mechanisms of action that can augment traditional chemotherapy. As these agents are often used in combination with traditional chemotherapy testing the effects of these novel agents has proven difficult requiring large sample sizes to detect relatively small differences in patient survival. Despite the wide variety of mechanisms, most new drugs are thought to ultimately induce apoptosis of tumor cells or their supportive vasculature. Imaging agents that can non-invasively monitor apoptosis in response to these new drugs could therefore help streamline the drug development process. They may also help guide oncologists to identify those patients that could best benefit from a given therapeutic regimen, dose, or duration of drug. In this article we will outline the existing imaging agents and modalities that are currently undergoing clinical testing and those that could be rapidly translated into humans.
    MeSH term(s) Antineoplastic Agents/pharmacology ; Apoptosis/drug effects ; Autophagy ; Caspases/metabolism ; Humans ; Magnetic Resonance Imaging ; Poly (ADP-Ribose) Polymerase-1 ; Poly(ADP-ribose) Polymerases/metabolism ; Positron-Emission Tomography ; Signal Transduction ; Tomography, Emission-Computed, Single-Photon
    Chemical Substances Antineoplastic Agents ; PARP1 protein, human (EC 2.4.2.30) ; Poly (ADP-Ribose) Polymerase-1 (EC 2.4.2.30) ; Poly(ADP-ribose) Polymerases (EC 2.4.2.30) ; Caspases (EC 3.4.22.-)
    Language English
    Publishing date 2010-03-10
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 2217610-X
    ISSN 1875-5992 ; 1871-5206
    ISSN (online) 1875-5992
    ISSN 1871-5206
    DOI 10.2174/187152009789377727
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Imaging the molecular signatures of apoptosis and injury with radiolabeled annexin V.

    Blankenberg, Francis G

    Proceedings of the American Thoracic Society

    2009  Volume 6, Issue 5, Page(s) 469–476

    Abstract: Annexin V is a ubiquitous intracellular protein in humans that has a variety of intriguing characteristics, including a nanomolar affinity for the membrane-bound constitutive anionic phospholipid known as phosphatidylserine (PS). PS is selectively ... ...

    Abstract Annexin V is a ubiquitous intracellular protein in humans that has a variety of intriguing characteristics, including a nanomolar affinity for the membrane-bound constitutive anionic phospholipid known as phosphatidylserine (PS). PS is selectively expressed on the surface of apoptotic or physiologically stressed cells. As such, radiolabeled forms of annexin V have been used in both animal models and human Phase I and Phase II trials to determine if this tracer can be employed as an early surrogate marker of therapeutic efficacy in NSCLC and non-Hodgkin's lymphoma. Many other pulmonary imaging applications of radiolabeled annexin V are also possible, including the detection and monitoring of active pulmonary inflammation and other pathophysiologic stressors in a variety of diseases. In this article, the salient molecular features of apoptosis (and other forms of cell death) that permits imaging with radiolabeled annexin V will be discussed. The latest results from Phase II imaging trials with NSCLC and non-Hodgkin's lymphoma will be also be detailed. Finally, the potential future application of this tracer for the imaging of other pulmonary pathologies will be outlined.
    MeSH term(s) Annexin A5 ; Apoptosis/physiology ; Autophagy ; Fluorodeoxyglucose F18 ; Humans ; Lung Diseases/diagnosis ; Lung Diseases/physiopathology ; Molecular Imaging/methods ; Positron-Emission Tomography ; Radiopharmaceuticals ; Tomography, Emission-Computed, Single-Photon
    Chemical Substances Annexin A5 ; Radiopharmaceuticals ; Fluorodeoxyglucose F18 (0Z5B2CJX4D)
    Language English
    Publishing date 2009-08-17
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2132421-9
    ISSN 1943-5665 ; 1546-3222
    ISSN (online) 1943-5665
    ISSN 1546-3222
    DOI 10.1513/pats.200901-001AW
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Immunomodulation Therapy Using Tolerogenic Macrophages in a Rodent Model of Pulmonary Hypertension.

    Guihaire, Julien / Deuse, Tobias / Wang, Dong / Spin, Joshua M / Blankenberg, Francis G / Fadel, Elie / Reichenspurner, Hermann / Schrepfer, Sonja

    Stem cells and development

    2021  Volume 30, Issue 10, Page(s) 515–525

    Abstract: Inflammation plays a major role in the pathogenesis of pulmonary hypertension (PH). We sought to investigate the effects of a cell-based immunomodulation in a dysimmune model of PH. PH was induced in athymic nude rats using semaxinib (Su group, ...

    Abstract Inflammation plays a major role in the pathogenesis of pulmonary hypertension (PH). We sought to investigate the effects of a cell-based immunomodulation in a dysimmune model of PH. PH was induced in athymic nude rats using semaxinib (Su group,
    MeSH term(s) Animals ; Disease Models, Animal ; Gene Expression Profiling/methods ; Humans ; Hypertension, Pulmonary/immunology ; Hypertension, Pulmonary/physiopathology ; Hypertension, Pulmonary/therapy ; Immune Tolerance/immunology ; Immunomodulation/immunology ; Immunotherapy/methods ; Indoles/pharmacology ; Lung/drug effects ; Lung/metabolism ; Lung/physiopathology ; Macrophages/immunology ; Male ; Nerve Tissue Proteins/genetics ; Nerve Tissue Proteins/metabolism ; Potassium Channels, Tandem Pore Domain/genetics ; Potassium Channels, Tandem Pore Domain/metabolism ; Protein Kinase Inhibitors/pharmacology ; Pyrroles/pharmacology ; Rats, Nude ; Rodentia ; Stroke Volume/drug effects ; Stroke Volume/immunology ; Stroke Volume/physiology ; Tomography, Emission-Computed, Single-Photon ; Rats
    Chemical Substances Indoles ; Nerve Tissue Proteins ; Potassium Channels, Tandem Pore Domain ; Protein Kinase Inhibitors ; Pyrroles ; potassium channel subfamily K member 3 (1HQ3YCN4GS) ; Semaxinib (71IA9S35AJ)
    Language English
    Publishing date 2021-04-16
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2142214-X
    ISSN 1557-8534 ; 1547-3287
    ISSN (online) 1557-8534
    ISSN 1547-3287
    DOI 10.1089/scd.2021.0007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: In vivo imaging of apoptosis.

    Blankenberg, Francis G

    Cancer biology & therapy

    2008  Volume 7, Issue 10, Page(s) 1525–1532

    Abstract: Despite over a decade of intense investigation there is still no routine method for the clinical imaging of apoptosis in oncologic patients. There have been multiple tracers proposed but none as of yet has received FDA approval. Radiolabeled annexin V is ...

    Abstract Despite over a decade of intense investigation there is still no routine method for the clinical imaging of apoptosis in oncologic patients. There have been multiple tracers proposed but none as of yet has received FDA approval. Radiolabeled annexin V is one of the few radiotracers that has been widely used in Phase II trials and is still under development. In this review we will first detail the general mechanisms involved with apoptosis and other common forms of cell death. Next we will outline the latest in vivo imaging data in animal models and humans including that obtained with radiolabeled annexin V. It is hoped that improved understanding of the complex biochemical pathways involved with cell death will lead to at least several radiopharmaceuticals with the ability to image apoptosis as part of improving the care and treatment of patients suffering from cancer.
    MeSH term(s) Aged ; Animals ; Annexin A5/chemistry ; Apoptosis ; Autophagy ; Clinical Trials as Topic ; Diagnostic Imaging/instrumentation ; Diagnostic Imaging/methods ; Fluorodeoxyglucose F18/pharmacology ; Humans ; Male ; Mitochondria/metabolism ; Neoplasms/diagnosis ; Neoplasms/diagnostic imaging ; Proteasome Endopeptidase Complex/metabolism ; Radionuclide Imaging ; Radiopharmaceuticals ; Signal Transduction
    Chemical Substances Annexin A5 ; Radiopharmaceuticals ; Fluorodeoxyglucose F18 (0Z5B2CJX4D) ; Proteasome Endopeptidase Complex (EC 3.4.25.1)
    Language English
    Publishing date 2008-10-07
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 2146305-0
    ISSN 1555-8576 ; 1538-4047
    ISSN (online) 1555-8576
    ISSN 1538-4047
    DOI 10.4161/cbt.7.10.6934
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: In vivo detection of apoptosis.

    Blankenberg, Francis G

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    2008  Volume 49 Suppl 2, Page(s) 81S–95S

    Abstract: After several decades of debate, it is now widely acknowledged that apoptosis, also known as programmed cell death, is central to homoeostasis and normal development and physiology in all multicellular organisms, including humans. The dysregulation of ... ...

    Abstract After several decades of debate, it is now widely acknowledged that apoptosis, also known as programmed cell death, is central to homoeostasis and normal development and physiology in all multicellular organisms, including humans. The dysregulation of apoptosis can lead to the destruction of normal tissues in a variety of disorders, including autoimmune and neurodegenerative diseases (too much apoptosis) or the growth of tumors (too little apoptosis). In addition, effective therapy of tumors requires the iatrogenic induction of programmed cell death by radiation, chemotherapy, or both. Given the central role of apoptosis, it would be desirable to have a noninvasive imaging method to serially detect and monitor this process in cancer patients undergoing conventional radiation and chemotherapy treatments as well as for the development and testing of new drugs. In this article, the latest modalities and contrast agents described in the literature for the imaging of apoptosis in vivo are reviewed. First, the most recent developments in the biochemical characterization of the many intracellular pathways involved in this complex process are discussed. Next, a variety of new radionuclide tracers, including radiolabeled annexin V and caspase inhibitors for PET and SPECT, are described. Finally, the use of MRI, MR spectroscopy, and ultrasound as possible alternative imaging modalities for the imaging of apoptosis is addressed.
    MeSH term(s) Animals ; Annexin A5/physiology ; Apoptosis/physiology ; Caspase Inhibitors ; Caspases/metabolism ; Cell Death/physiology ; Contrast Media ; Humans ; Lipid Metabolism ; Magnetic Resonance Imaging ; Mice ; Neoplasms/diagnostic imaging ; Neoplasms/metabolism ; Neoplasms/pathology ; Positron-Emission Tomography ; Radiopharmaceuticals ; Ultrasonography
    Chemical Substances Annexin A5 ; Caspase Inhibitors ; Contrast Media ; Radiopharmaceuticals ; Caspases (EC 3.4.22.-)
    Language English
    Publishing date 2008-06
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 80272-4
    ISSN 1535-5667 ; 0161-5505 ; 0097-9058 ; 0022-3123
    ISSN (online) 1535-5667
    ISSN 0161-5505 ; 0097-9058 ; 0022-3123
    DOI 10.2967/jnumed.107.045898
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Recent advances in the molecular imaging of programmed cell death: Part II--non-probe-based MRI, ultrasound, and optical clinical imaging techniques.

    Blankenberg, Francis G / Strauss, H William

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    2013  Volume 54, Issue 1, Page(s) 1–4

    Abstract: There is much that can be done to detect apoptosis and other forms of cell death with existing clinical modalities including ultrasound, MRI, and optical imaging without the need for current or new intravenous contrast agents. We will discuss how these ... ...

    Abstract There is much that can be done to detect apoptosis and other forms of cell death with existing clinical modalities including ultrasound, MRI, and optical imaging without the need for current or new intravenous contrast agents. We will discuss how these widely available imaging technologies can readily be applied to the imaging of apoptosis in patients undergoing chemotherapy or radiation treatment. The limiting factor of course is the lack of knowledge of the optimal times after the start of treatment for the most accurate assessment of apoptosis and necrosis with each modality and specific technique. It is hoped that imaging studies that systematically look at treatment response can soon be performed to address these issues.
    MeSH term(s) Animals ; Apoptosis ; Humans ; Magnetic Resonance Imaging/methods ; Molecular Imaging/methods ; Neoplasms/diagnosis ; Neoplasms/pathology ; Neoplasms/therapy ; Optical Imaging/methods ; Ultrasonography/methods
    Language English
    Publishing date 2013-01
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 80272-4
    ISSN 1535-5667 ; 0097-9058 ; 0161-5505 ; 0022-3123
    ISSN (online) 1535-5667
    ISSN 0097-9058 ; 0161-5505 ; 0022-3123
    DOI 10.2967/jnumed.112.111740
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Monitoring of treatment-induced apoptosis in oncology with PET and SPECT.

    Blankenberg, Francis G

    Current pharmaceutical design

    2006  Volume 14, Issue 28, Page(s) 2974–2982

    Abstract: The early assessment of a solid tumor's response to conventional or new drug therapy to complement or replace current RECIST (or other clinical) criteria remains an elusive goal. The work horse PET tracer (18)F-FDG, may represent the most immediate ... ...

    Abstract The early assessment of a solid tumor's response to conventional or new drug therapy to complement or replace current RECIST (or other clinical) criteria remains an elusive goal. The work horse PET tracer (18)F-FDG, may represent the most immediate method to track individual tumor response to therapy for many types of cancer. Newer radiotracers such as radiolabeled annexin V, have also shown the ability to selectively localize to tumor cells undergoing apoptosis (programmed cell death) in response to successful treatment in vivo. In this article we will review therapy reduced tumor apoptosis and the radiotracers used to date to image this process in both animal models and clinical trials.
    MeSH term(s) Animals ; Annexin A5/pharmacokinetics ; Antineoplastic Agents/pharmacology ; Apoptosis/drug effects ; Clinical Trials as Topic ; Disease Models, Animal ; Humans ; Neoplasms/diagnostic imaging ; Neoplasms/drug therapy ; Radiopharmaceuticals/pharmacokinetics ; Tomography, Emission-Computed/methods ; Tomography, Emission-Computed, Single-Photon/methods
    Chemical Substances Annexin A5 ; Antineoplastic Agents ; Radiopharmaceuticals
    Language English
    Publishing date 2006-01-23
    Publishing country United Arab Emirates
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 1304236-1
    ISSN 1873-4286 ; 1381-6128
    ISSN (online) 1873-4286
    ISSN 1381-6128
    DOI 10.2174/138161208786404353
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A novel roadmap connecting the 1H-MRS total choline resonance to all hallmarks of cancer following targeted therapy

    Egidio Iorio / Franca Podo / Martin O. Leach / Jason Koutcher / Francis G. Blankenberg / Joseph F. Norfray

    European Radiology Experimental, Vol 5, Iss 1, Pp 1-

    2021  Volume 14

    Abstract: Abstract This review describes a cellular adaptive stress signalling roadmap connecting the 1H magnetic resonance spectroscopy (MRS) total choline peak at 3.2 ppm (tCho) to cancer response after targeted therapy (TT). Recent research on cell signalling, ... ...

    Abstract Abstract This review describes a cellular adaptive stress signalling roadmap connecting the 1H magnetic resonance spectroscopy (MRS) total choline peak at 3.2 ppm (tCho) to cancer response after targeted therapy (TT). Recent research on cell signalling, tCho metabolism, and TT of cancer has been retrospectively re-examined. Signalling research describes how the unfolded protein response (UPR), a major stress signalling network, transduces, regulates, and rewires the total membrane turnover in different cancer hallmarks after a TT stress. In particular, the UPR signalling maintains or increases total membrane turnover in all pro-survival hallmarks, whilst dramatically decreases turnover during apoptosis, a pro-death hallmark. Recent research depicts the TT-induced stress as a crucial event responsible for interrupting UPR pro-survival pathways, leading to an UPR-mediated cell death. The 1H-MRS tCho resonance represents the total mobile precursors and products during the enzymatic modification of phosphatidylcholine membrane abundance. The tCho profile represents a biomarker that noninvasively monitors TT-induced enzymatic changes in total membrane turnover in a wide variety of existing and new anticancer treatments targeting specific layers of the UPR signalling network. Our overview strongly suggests further evaluating and validating the 1H-MRS tCho peak as a powerful noninvasive imaging biomarker of cancer response in TT clinical trials.
    Keywords Biomarkers ; Choline ; Magnetic resonance spectroscopy ; Neoplasms ; Unfolded protein response ; Medical physics. Medical radiology. Nuclear medicine ; R895-920
    Subject code 570
    Language English
    Publishing date 2021-01-01T00:00:00Z
    Publisher SpringerOpen
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top